Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
104.86
+1.91 (1.86%)
At close: May 15, 2025, 4:00 PM
105.10
+0.24 (0.23%)
After-hours: May 15, 2025, 7:59 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
According to 23 professional analysts, the 12-month price target for Boston Scientific stock ranges from a low of $78 to a high of $130. The average analyst price target of $110.57 forecasts a 5.45% increase in the stock price over the next year.
Price Target: $110.57 (+5.45%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 12 |
| Buy | 9 | 9 | 10 | 10 | 10 | 10 |
| Hold | 3 | 3 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $118 → $125 | Buy | Maintains | $118 → $125 | +19.21% | Apr 25, 2025 |
| Needham | Needham | Strong Buy Maintains $113 → $115 | Strong Buy | Maintains | $113 → $115 | +9.67% | Apr 24, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $116 → $120 | Buy | Maintains | $116 → $120 | +14.44% | Apr 24, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $113 → $117 | Strong Buy | Maintains | $113 → $117 | +11.58% | Apr 24, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $110 → $112 | Buy | Maintains | $110 → $112 | +6.81% | Apr 24, 2025 |
Financial Forecast
Revenue This Year
19.39B
from 16.75B
Increased by 15.77%
Revenue Next Year
21.39B
from 19.39B
Increased by 10.33%
EPS This Year
2.89
from 1.25
Increased by 131.13%
EPS Next Year
3.29
from 2.89
Increased by 13.96%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.6B | 22.8B | 25.1B | ||
| Avg | 19.4B | 21.4B | 23.5B | ||
| Low | 18.6B | 20.4B | 22.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.2% | 17.6% | 17.1% | ||
| Avg | 15.8% | 10.3% | 9.9% | ||
| Low | 11.2% | 5.1% | 4.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.13 | 3.70 | 4.07 | ||
| Avg | 2.89 | 3.29 | 3.71 | ||
| Low | 2.74 | 3.10 | 3.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 150.3% | 27.9% | 23.7% | ||
| Avg | 131.1% | 14.0% | 12.8% | ||
| Low | 119.5% | 7.2% | 4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.